Pertussis epidemic despite high levels of vaccination coverage with acellular pertussis vaccine

Enfermedades Infecciosas y Microbiologia Clinica - Tập 33 - Trang 27-31 - 2015
Maria-Rosa Sala-Farré1, César Arias-Varela1, Assumpta Recasens-Recasens1, Maria Simó-Sanahuja2, Carmen Muñoz-Almagro3, Josefa Pérez-Jové2
1Unitat de Vigilància Epidemiològica Vallès Occidental i Vallès Oriental, Public Health Agency of Catalonia, Sant Cugat del Vallès, Barcelona, Spain
2Servei de Microbiologia, CATLAB, Parc Logístic de Salut, Viladecavalls, Barcelona, Spain
3Departamento de Microbiología Molecular, Hospital Universitario Sant Joan de Déu, Esplugues de Llobregat, Barcelona, Spain

Tài liệu tham khảo

American Academy of Pediatrics, 2012, 553 Cherry, 2007, Historical perspective on pertussis and use of vaccines to prevent it, Microbe, 2, 139 Barret, 2010, Pertussis outbreak in northwest Ireland, January–June 2010, Euro Surveill, 15, 1, 10.2807/ese.15.35.19654-en Centers for Diseases Control and Prevention, 2012, Pertussis epidemic—Washington, 2012, MMWR, 61, 517 Campins, 2013, Tos ferina en España. Situación epidemiológica y estrategias de prevención y control. Recomendaciones del Grupo de Trabajo de Tos ferina, Enferm Infecc Microbiol Clin, 31, 240, 10.1016/j.eimc.2012.12.011 Calentano, 2005, Resurgence of pertussis in Europe, Pediatr Infect Dis J, 24, 761, 10.1097/01.inf.0000177282.53500.77 Vera, 2007, Incidence trends in pertussis in the Autonomous Region of Madrid, Spain: 1982–2005, Euro Surveill, 12, 209, 10.2807/esm.12.09.00731-en Manzanares, 2013, Evolución de la incidencia de tos ferina en la ciudad de Barcelona entre 1999 y 2011, Enferm Infecc Microbiol Clin, 31, 156, 10.1016/j.eimc.2012.06.013 Borràs, 2007, Vaccination coverage in indigenous and immigrant children under 3 years of age in Catalonia (Spain), Vaccine, 25, 3240, 10.1016/j.vaccine.2007.01.026 Crespo, 2011, Epidemiology of pertussis in a country with high vaccination coverage, Vaccine, 29, 4244, 10.1016/j.vaccine.2011.03.065 Petersen, 2012, Temporal tends in Bordetella pertussis populations, Denmark, 1949–2010, Emerg Infect Dis, 18, 767, 10.3201/eid1805.110812 Schmidtke, 2012, Population diversity among Bordetella pertussis isolates, United States, 1935–2009, Emerg Infect Dis, 18, 1248, 10.3201/eid1808.120082 Stehr, 1998, A comparative efficacy trial in Germany in infants who receive either the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine, or DT vaccine, Pediatrics, 101, 1, 10.1542/peds.101.1.1 Winter, 2012, California pertussis epidemic, 2010, J Pediatr, 161, 1091, 10.1016/j.jpeds.2012.05.041 Witt, 2012, Unexpectedly limited durability of immunity following acellular pertussis vaccination in preadolescents in a North American outbreak, Clin Infect Dis, 54, 1730, 10.1093/cid/cis287 European Centre for Disease Control. ECDC technical document, 2012 Chan, 2012, The California pertussis epidemic 2010: a review of 986 pediatric case reports from San Diego County, J Pediatr Infect Dis, 1, 47, 10.1093/jpids/pis007 Klein, 2012, Waning protection after fifth dose of acellular pertussis vaccine in children, N Engl J Med, 367, 1012, 10.1056/NEJMoa1200850 Tartof, 2013, Waning immunity to pertussis following 5 doses of DTaP, Pediatrics, 10.1542/peds.2012-1928 Witt, 2013, Reduced risk of pertussis among persons ever vaccinated with whole cell pertussis vaccine compared to recipients of acellular pertussis vaccines in a large US Cohort, Clin Infect Dis, 56, 1248, 10.1093/cid/cit046 Cherry, 2005, The epidemiology of pertussis: a comparison of the epidemiology of the disease pertussis with the epidemiology of Bordetella pertussis infection, Pediatrics, 115, 1422, 10.1542/peds.2004-2648 Centers for Diseases Control and Prevention, 2005, Pertussis—United States, 2001–2003, MMWR, 54, 1283 Lavine, 2005, Imperfect vaccine-induced immunity and whooping cough transmission to infants, Vaccine, 29, 11, 10.1016/j.vaccine.2010.10.029 Jardine, 2010, Who gives pertussis to infants? Source of infection for laboratory confirmed cases less than 12 months of age during an epidemic, Sydney, 2009, Commun Dis Intell Q Rep, 34, 116 Wendeloe, 2007, Transmission of Bordetella pertussis to young infants, Pediatr Infect Dis J, 26, 293, 10.1097/01.inf.0000258699.64164.6d European Centre for Disease Control. ECDC Guidance, 2009 Cherry, 2012, Clinical definitions of pertussis: summary of Global Pertussis Initiative Roundtable Meeting February 2011, Clin Infect Dis, 54, 1756, 10.1093/cid/cis302 Ridda, 2012, The importance of pertussis in older adults: a growing case for reviewing vaccination strategy in the elderly, Vaccine, 30, 6745, 10.1016/j.vaccine.2012.08.079 Gregory, 2006, Pertussis: a disease affecting all ages, Am Fam Physician, 74, 420 Clarke, 2013, The pertussis epidemic: informing strategies for prevention of severe disease, Epidemiol Infect, 141, 463, 10.1017/S095026881200091X Zepp, 2011, Source Rationale for pertussis booster vaccination throughout life in Europe Lancet Infect Dis, 11, 557 Shinall, 2008, Potential impact of acceleration of the pertussis vaccine primary series for infants, Pediatrics, 122, 1021, 10.1542/peds.2007-3025 Knuf, 2008, Neonatal vaccination with an acellular pertussis vaccine accelerates the acquisition of pertussis antibodies in infants, J Pediatrics, 152, 655, 10.1016/j.jpeds.2007.09.034 Baraff, 1984, Immunologic response to early and routine DTP immunization in infants, Pediatrics, 73, 37, 10.1542/peds.73.1.37